Regulation 30 Amendment of regulation 39 (further requirements for manufacturer's licence)I1
United Kingdom
(b)
after “and (6)” insert “ and, where the product is being distributed in Northern Ireland, regulation 43A, ”.
Annotations
Textual amendments
- F1
Words in reg. 30 renumbered as reg. 30(a) (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 20(a)
- F2
Reg. 30(b) and word inserted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 20(b)
Marginal citations
- M1
Regulation 39 was amended by S.I. 2013/1855, 2015/354 and 2019/62.
Commencement
- I1
Reg. 30 in force on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1